Loading..
Processing... Please wait...

Product was successfully added to your shopping cart.



2014 Berakah Mediaesthetics Pte Ltd. All Rights Reserved.
Tel: +65 91837524
 
0 item(s) - S$0.00

Recently added item(s)

You have no items in your shopping cart.

  • NanoMD® Bright Supplement 30 Tabs

NanoMD® Bright Supplement 30 Tabs

Supplement. Oral sunblock. Skin lightening, Reduce pigment production. Antioxidant. Anti-age.

12% off retail price for more than 3 boxes.

15% off retail price for more than 6 boxes.

Regular Price: S$179.00

-10%

Special Price: S$161.10

Availability: In Stock

Product Code: Supp-NanoMD

Description
FREE SHIPPING anywhere in Singapore only.
For overseas orders outside of Singapore, whatsapp us at +65 9183 7524.

THE NANOMD® BRIGHT IS THE WORLD'S NEWEST AND MOST ADVANCED SUPPLEMENT FOR SKIN PROTECTION, NUTRITION AND BRIGHTENING. IT REPRESENTS THE CUTTING-EDGE SCIENTIFIC DISCOVERY IN NUTRITION AND NANO TECHNOLOGY IN A ONE-TABLET-A-DAY FORM.


Certified Vegan. Made in USA. Safe during breastfeeding.
30 Tabs / box

Ingredients: Pygnogenol. Tomato Phytoconcentrate. L-cysteine 


Precautions
Do not consume NanoMD Bright if you are allergic to any of the ingredients contained in NanoMD Bright.
Details

Dermagold is an authorized partner of NanoMD Bright. 

Clinical Trials

NanoMD® was developed by a multi-disciplinary team of world-class researchers and developers. It utilizes nanotechnologies that radically improve the bioavailability of chemical compounds used in pharmaceuticals & nutraceuticals. NanoMD® contains patented ingredients. Use of the product is protected by one or more U.S. and other international patents.

Novel Supplement with Phenolic Compounds for Treatment of Melasma: Double Blind Placebo Controlled Trial Safety and Efficacy Evaluation, Corresponding Author: Downie, J. B., MD, FAAD, Image Dermatology, Montclair, NJ, USA; Journal: Dermatology and Dermatologic Diseases, 5(1).; Copyright: © 2018 Downie J, et al.

 

Background: Melasma is a chronic skin problem that causes dark, discolored patches on the skin and therefore can have adverse effects on quality of life. Recently, a novel complex was shown to decrease melasma. Specifically, the goal of the study was to prove that the formula can reduce melasma, overall hyperpigmentation and nontransient erythema.

Methods: Forty subjects with Fitzpatrick skin types III-V were enrolled in the double-blinded, randomized, placebo controlled trial: 20 were treated over 90 days with the oral supplement and 20 received a placebo over 90 days. Subjects were assessed at onset and re-assessed at 60 and 90 days by the Modified Melasma Area and Severity Index (mMASI), photographic documentation, hyperpigmentation tool, erythema index and client satisfaction. Subjects used the product or a placebo (in tablet form) orally once a day.

Conclusion: Consistent, statistically significant reductions in melasma, as measured by mMASI scores, overall hyperpigmentation and non-transient erythema scores were achieved while meeting patient expectations at the 90 day follow-up evaluation point when compared to placebo. Results from this clinical trial suggest that this oral supplement is an effective treatment for melasma and may provide an alternative treatment for overall hyperpigmentation and non-transient erythema, while meeting expectations of patients. The product was well tolerated, with no reports of adverse events or side effects.